Literature DB >> 9345651

Diabetic neuropathies.

A A Sima1, P K Thomas, D Ishii, A Vinik.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9345651     DOI： 10.1007/bf03168192

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats.

Authors:  H X Zhuang; C K Snyder; S F Pu; D N Ishii
Journal:  Exp Neurol       Date:  1996-08       Impact factor: 5.330

Review 2.  Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology.

Authors: 
Journal:  Diabetes Care       Date:  1988 Jul-Aug       Impact factor: 19.112

3.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

Authors:  A A Sima; V Nathaniel; V Bril; T A McEwen; D A Greene
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 4.  Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy.

Authors:  D N Ishii
Journal:  Brain Res Brain Res Rev       Date:  1995-01

5.  Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy.

Authors:  I N Migdalis; K Kalogeropoulou; L Kalantzis; C Nounopoulos; A Bouloukos; M Samartzis
Journal:  Diabet Med       Date:  1995-09       Impact factor: 4.359

6.  Successful treatment of neuropathies in patients with diabetes mellitus.

Authors:  D A Krendel; D A Costigan; L C Hopkins
Journal:  Arch Neurol       Date:  1995-11
  6 in total
  8 in total

1.  Diabetic Neuropathies.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  Management of painful diabetic neuropathy: what is new or in the pipeline for 2007?

Authors:  Dan Ziegler
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

Review 3.  [Diabetic complications. Micro and macroangiopathic end-organ damage].

Authors:  U D Lichtenauer; J Seissler; W A Scherbaum
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

4.  Outpatient management of type 2 diabetic patients: a review of evidence-based literature.

Authors:  Eiad A Al-Faris; Hussein S Amin; Mohammed O Al-Rukban
Journal:  J Family Community Med       Date:  2006-01

5.  Therapeutic effects of fenofibrate on diabetic peripheral neuropathy by improving endothelial and neural survival in db/db mice.

Authors:  Ye Rim Cho; Ji Hee Lim; Min Young Kim; Tae Woo Kim; Bo Young Hong; Yong-Soo Kim; Yoon Sik Chang; Hye Won Kim; Cheol Whee Park
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

6.  Calcimimetic restores diabetic peripheral neuropathy by ameliorating apoptosis and improving autophagy.

Authors:  You Chul Chung; Ji Hee Lim; Hyun Mi Oh; Hyung Wook Kim; Min Young Kim; Eun Nim Kim; Yaeni Kim; Yoon Sik Chang; Hye Won Kim; Cheol Whee Park
Journal:  Cell Death Dis       Date:  2018-11-26       Impact factor: 8.469

7.  Herbal medicine foot bath for the treatment of diabetic peripheral neuropathy: protocol for a randomized, double-blind and controlled trial.

Authors:  Guanjie Fan; Haoyue Huang; Yuping Lin; Guoqing Zheng; Xianyu Tang; Yu Fu; Hua Wei; Ling Zhao; Zhenjie Liu; Mei Wang; Shidong Wang; Qingbo Li; Zhaohui Fang; Yuehong Zhou; Fang Dai; Xiaotang Qiu
Journal:  Trials       Date:  2018-09-10       Impact factor: 2.279

8.  Attenuation of Cortically Evoked Motor-Neuron Potential in Streptozotocin-Induced Diabetic Rats: A Study about the Effect of Diabetes upon Cortical-Initiated Movement.

Authors:  Jesper Guldsmed Madsen; Jakob Appel Østergaard; Henning Andersen; Michael Pedersen
Journal:  Biomed Res Int       Date:  2020-02-25       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.